125 related articles for article (PubMed ID: 35810565)
1. RGS10 suppression by DNA methylation is associated with low survival rates in colorectal carcinoma.
Caldiran FY; Cacan E
Pathol Res Pract; 2022 Aug; 236():154007. PubMed ID: 35810565
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells.
Ali MW; Cacan E; Liu Y; Pierce JY; Creasman WT; Murph MM; Govindarajan R; Eblen ST; Greer SF; Hooks SB
PLoS One; 2013; 8(3):e60185. PubMed ID: 23533674
[TBL] [Abstract][Full Text] [Related]
3. Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.
Hooks SB; Callihan P; Altman MK; Hurst JH; Ali MW; Murph MM
Mol Cancer; 2010 Nov; 9():289. PubMed ID: 21044322
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance.
Cacan E; Ali MW; Boyd NH; Hooks SB; Greer SF
PLoS One; 2014; 9(1):e87455. PubMed ID: 24475290
[TBL] [Abstract][Full Text] [Related]
5. Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas.
Tang Z; Liu L; Borlak J
Clin Epigenetics; 2023 May; 15(1):89. PubMed ID: 37208732
[TBL] [Abstract][Full Text] [Related]
6. Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells.
Altman MK; Alshamrani AA; Jia W; Nguyen HT; Fambrough JM; Tran SK; Patel MB; Hoseinzadeh P; Beedle AM; Murph MM
Cancer Lett; 2015 Dec; 369(1):175-83. PubMed ID: 26319900
[TBL] [Abstract][Full Text] [Related]
7. RGS10 Regulates the Expression of Cyclooxygenase-2 and Tumor Necrosis Factor Alpha through a G Protein-Independent Mechanism.
Alqinyah M; Almutairi F; Wendimu MY; Hooks SB
Mol Pharmacol; 2018 Oct; 94(4):1103-1113. PubMed ID: 30049816
[TBL] [Abstract][Full Text] [Related]
8. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
Li DJ; Feng ZC; Li XR; Hu G
World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
[TBL] [Abstract][Full Text] [Related]
9. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
10. A broad analysis in clinical and in vitro models on regulator of G-protein signalling 10 regulation that is associated with ovarian cancer progression and chemoresistance.
Kucuk B; Kibar B; Cacan E
Cell Biochem Funct; 2021 Apr; 39(3):413-422. PubMed ID: 33354811
[TBL] [Abstract][Full Text] [Related]
11. Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment.
Yu G; Wu Y; Wang W; Xu J; Lv X; Cao X; Wan T
Cell Mol Immunol; 2019 Apr; 16(4):401-409. PubMed ID: 29622799
[TBL] [Abstract][Full Text] [Related]
12. Cellular deficiency in the RGS10 protein facilitates chemoresistant ovarian cancer.
Hooks SB; Murph MM
Future Med Chem; 2015 Aug; 7(12):1483-9. PubMed ID: 26293348
[TBL] [Abstract][Full Text] [Related]
13. Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma.
Li JB; Liu ZX; Zhang R; Ma SP; Lin T; Li YX; Yang SH; Zhang WC; Wang YP
World J Gastroenterol; 2019 Jun; 25(22):2776-2787. PubMed ID: 31236000
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel DNA hypermethylation of the adenylate kinase 5 promoter in colorectal adenocarcinoma.
Ahn B; Chae YS; Lee SK; Kim M; Kim HS; Moon JW; Park SH
Sci Rep; 2021 Jun; 11(1):12626. PubMed ID: 34135408
[TBL] [Abstract][Full Text] [Related]
16. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
[TBL] [Abstract][Full Text] [Related]
17. Regulator of G protein signaling 10: Structure, expression and functions in cellular physiology and diseases.
Almutairi F; Lee JK; Rada B
Cell Signal; 2020 Nov; 75():109765. PubMed ID: 32882407
[TBL] [Abstract][Full Text] [Related]
18. Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer.
Arechavaleta-Velasco F; Dominguez-Lopez P; Acosta-Jimenez E; Diaz-Cueto L
Mol Biol Rep; 2023 Aug; 50(8):6863-6870. PubMed ID: 37402066
[TBL] [Abstract][Full Text] [Related]
19. CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway.
Graule J; Uth K; Fischer E; Centeno I; Galván JA; Eichmann M; Rau TT; Langer R; Dawson H; Nitsche U; Traeger P; Berger MD; Schnüriger B; Hädrich M; Studer P; Inderbitzin D; Lugli A; Tschan MP; Zlobec I
Clin Epigenetics; 2018 Sep; 10(1):120. PubMed ID: 30257705
[TBL] [Abstract][Full Text] [Related]
20. The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer.
Park DY; Sakamoto H; Kirley SD; Ogino S; Kawasaki T; Kwon E; Mino-Kenudson M; Lauwers GY; Chung DC; Rueda BR; Zukerberg LR
Am J Pathol; 2007 Nov; 171(5):1509-19. PubMed ID: 17982127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
